2Q19—Biotech funding stagnates

Overview of attention for news story in Nature Biotechnology

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,466 followers.

RT @andz79: Q2 2019 sees a dip in Biotech VC funding after a strong Q1. Cancer and Gene therapy dominate life science therapeutic areas att…

06 Aug 2019

Reply Repost Favourite

Q2 2019 sees a dip in Biotech VC funding after a strong Q1. Cancer and Gene therapy dominate life science therapeutic areas attracting maximum funds. Thanks to Daniel Parisotto, PhD for sharing the article. https://t.co/zrp0jhiMc6

06 Aug 2019

Reply Repost Favourite